|
|
Volumn 177, Issue 1, 2014, Pages 209-210
|
|
Real-life use of the polypill components (ASA + ACEI + statins) after an acute coronary syndrome and long-term mortality
a
a
a
a
a
a
a,b
|
|
Author keywords
Acute coronary syndrome; Mortality; Polypill
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ACUTE CORONARY SYNDROME;
ADULT;
CARDIOGENIC SHOCK;
CARDIOVASCULAR MORTALITY;
CARDIOVASCULAR RISK;
CAUSE OF DEATH;
COHORT ANALYSIS;
DRUG USE;
FEMALE;
FOLLOW UP;
HEART FAILURE;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
MEDICATION COMPLIANCE;
POLYPHARMACY;
PRESCRIPTION;
PREVENTION AND CONTROL;
RETROSPECTIVE STUDY;
RISK REDUCTION;
DRUG COMBINATION;
EPIDEMIOLOGY;
MIDDLE AGED;
MORTALITY;
SPAIN;
SURVIVAL RATE;
TIME;
TRENDS;
ACUTE CORONARY SYNDROME;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ASPIRIN;
CAUSE OF DEATH;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
SPAIN;
SURVIVAL RATE;
TIME FACTORS;
|
|
EID: 84909961838
PISSN: 01675273
EISSN: 18741754
Source Type: Journal
DOI: 10.1016/j.ijcard.2014.09.029 Document Type: Article |
|
Times cited : (8)
|
|
References (5)
|
